Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares
REYKJAVIK, ICELAND (June 15, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechn…
REYKJAVIK, ICELAND (June 15, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechn…
júní 2026) - Alvotech (NASDAQ: ALVO, ALVO SDB) tilkynnti í dag að félagið efni til sölutryggðs hlutafjárútboðs í Bandar…
Early mechanistic data positions ETHY-001 as a differentiated candidate in thyroid-eye disease, a space drawing growing…
Functional News covers ingredients, formulations, clinical evidence, and market trends in functional foods and nutraceu…
As the cognitive-wellness category accelerates, operators are eyeing whole-food ingredients with established safety pro…
The nicotine-free oral delivery format is gaining traction as a disruptive vector for nootropic and energy ingredients …
Submitted press release describes a university running event with no ingredient, clinical, regulatory, or market data r…
The Riyadh-based institution's Amsterdam appearance underscores growing Gulf investment in science-driven healthcare in…
Submitted release covers a hospital innovation conference in Amsterdam — outside Functional News editorial scope.
Annual pharmacist preference data carries growing weight for nutraceutical brands pursuing retail placement and structu…
The shift signals broader biotech convergence, but functional food and nutraceutical formulators should watch how AI-gu…
The San Diego showcase signals growing European crossover between biotech pipelines and finished formulation markets fo…